Overview

Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across...

Open

$0.00

Prior close

$1152.44

Today's high

$0.00

Today's low

$0.00

52 Week high

$1292.65

52 Week low

$712.05

News

WSJ • 11 hours ago • LLY

Patients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S.

24/7 Wall Street • 14 hours ago • LLY

Can Eli Lilly's Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation?

Reuters • 16 hours ago • LLY

US FDA approves Lilly's breast cancer drug combo

PRNewsWire • 17 hours ago • LLY

U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

Schwab Network • 19 hours ago • LLY

40% of U.S. Adults to Use GLP-1s? Raul Shah on LLY, NVO & Weight Loss "Mania"